Should we develop screens for multi-drug antibiotic tolerance?

References

• World Health Organization (WHO). Antimicrobial resistance: global report on surveillance 2014. [cited 2016 Apr 19]. Available from: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Antibiotic resistance threats in the United States, 2013. [cited 2016 Apr 19]. Available from: http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
   Google Scholar
• Review on Antimicrobial Resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. [cited 2016 Apr 19]. Available from: http://amr-review.org/sites/default/files/Report-52.15.pdf.
   Google Scholar
• Lin L, Nonejuie P, Munguia J, et al. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant Gram-negative bacterial pathogens. EBioMedicine. 2015;2(7):690–698.
   PubMed Web of Science ®Google Scholar
• Bigger JJW. Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet. 1944;244(6320):497–500.
   Google Scholar
• McCune RM, Tompsett R. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J Exp Med. 1956;104(5):737–762.
   PubMed Web of Science ®Google Scholar
• Brennan RO, Durack DT. Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrob Agents Chemother. 1983;23(2):273–277.
   PubMed Web of Science ®Google Scholar
• Novak R, Henriques B, Charpentier E, et al. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature. 1999;399(6736):590–593.
   PubMed Web of Science ®Google Scholar
• Tuomanen E, Durack DT, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother. 1986;30(4):521–527.
   PubMed Web of Science ®Google Scholar
• Okoro CK, Kingsley RA, Quail MA, et al. High-resolution single nucleotide polymorphism analysis distinguishes recrudescence and reinfection in recurrent invasive nontyphoidal Salmonella Typhimurium disease. Clin Infect Dis. 2012;54(7):955–963.
   PubMed Web of Science ®Google Scholar
• Ejrnaes K, Sandvang D, Lundgren B, et al. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. J Clin Microbiol. 2006;44(5):1776–1781.
   PubMed Web of Science ®Google Scholar
• Kim KS, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr. 1985;107(5):681–684.
   PubMed Web of Science ®Google Scholar
• McCullers JA, English BK, Novak R. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis. 2000;181(1):369–673.
   PubMed Web of Science ®Google Scholar
• Maisonneuve E, Gerdes K. Molecular mechanisms underlying bacterial persisters. Cell. 2014;157(3):539–548.
   PubMed Web of Science ®Google Scholar
• Fauvart M, De Groote VN, Michiels J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol. 2011;60(6):699–709.
   PubMed Web of Science ®Google Scholar
• Spoering AL, Lewis KIM. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol. 2001;183(23):6746–6751.
   PubMed Web of Science ®Google Scholar
• Helaine S, Cheverton AM, Watson KG, et al. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science. 2014;343(6167):204–208.
   PubMed Web of Science ®Google Scholar
• Kaiser P, Regoes RR, Dolowschiak T, et al. Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment. PLoS Biol. 2014;12(2):e1001793.
   PubMed Web of Science ®Google Scholar
• Goneau LW, Yeoh NS, MacDonald KW, et al. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrob Agents Chemother. 2014;58(4):2089–2097.
   PubMed Web of Science ®Google Scholar
• Stepanyan K, Wenseleers T, Duéñez-Guzmán EA, et al. Fitness trade-offs explain low levels of persister cells in the opportunistic pathogen Pseudomonas aeruginosa. Mol Ecol. 2015;24(7):1572–1583.
   Web of Science ®Google Scholar
• Mulcahy LR, Burns JL, Lory S, et al. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol. 2010;192(23):6191–6199.
   PubMed Web of Science ®Google Scholar
• Fridman O, Goldberg A, Ronin I, et al. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature. 2014;513(7518):418–421.
   PubMed Web of Science ®Google Scholar
• Mechler L, Herbig A, Paprotka K, et al. A novel point mutation promotes growth phase-dependent daptomycin tolerance in Staphylococcus aureus. Antimicrob Agents Chemother. 2015;59(5):5366–5376.
   PubMed Web of Science ®Google Scholar
• Van den Bergh B, Michiels JE, Wenseleers T, et al. Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat Microbiol. 2016;1:16020.
   PubMed Web of Science ®Google Scholar
• Michiels JE, Van den Bergh B, Verstraeten N, et al. In vitro emergence of high persistence upon periodic aminoglycoside challenge in the ESKAPE pathogens. Antimicrob Agents Chemother. 2016;60(8). doi:10.1128/AAC.00757–16.
   PubMedGoogle Scholar
• Levin BR, Rozen DE. Non-inherited antibiotic resistance. Nat Rev Microbiol. 2006;4(7):556–562.
   PubMed Web of Science ®Google Scholar
• Cohen NR, Lobritz MA, Collins JJ. Microbial persistence and the road to drug resistance. Cell Host Microbe. 2013;13(6):632–642.
   PubMed Web of Science ®Google Scholar
• Fleck LE, North EJ, Lee RE, et al. A screen for and validation of prodrug antimicrobials. Antimicrob Agents Chemother. 2014;58(3):1410–1419.
   PubMed Web of Science ®Google Scholar
• Haaber J, Friberg C, McCreary M, et al. Reversible antibiotic tolerance induced in Staphylococcus aureus by concurrent drug exposure. MBio. 2015;6(1):e02268–14.
   Web of Science ®Google Scholar
• Verstraeten AN, Knapen WJ, Kint CI, et al. Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance. Mol Cell. 2015;59(1):9–21.
   PubMed Web of Science ®Google Scholar
• Vogwill T, Comfort AC, Furió V, et al. Persistence and resistance as complementary bacterial adaptations to antibiotics. J Evol Biol. Forthcoming 2016. doi:10.1111/jeb.12864.
   PubMedGoogle Scholar
• Schumacher MA, Balani P, Min J, et al. HipBA–promoter structures reveal the basis of heritable multidrug tolerance. Nature. 2015;524(7563):59–64.
   PubMed Web of Science ®Google Scholar
• Allison KR, Brynildsen MP, Collins JJ. Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr Opin Microbiol. 2011;14(5):593–598.
   PubMed Web of Science ®Google Scholar
• Kwan BW, Chowdhury N, Wood TK. Combatting bacterial infections by killing persister cells with mitomycin C. Environ Microbiol. 2015;17(11):4406–4414.
   PubMed Web of Science ®Google Scholar
• Defraine V, Scheurmans J, Grymonprez B, et al. Efficacy of Artilysin® Art-175 against resistant and persistent Acinetobacter baumannii. Antimicrob Agents Chemother. 2016;60(6):3480–3488.
   PubMed Web of Science ®Google Scholar
• Conlon BP, Nakayasu ES, Fleck LE, et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 2013;503(7476):365–370.
   PubMed Web of Science ®Google Scholar
• Orman MA, Brynildsen MP. Persister formation in Escherichia coli can be inhibited by treatment with nitric oxide. Free Radic Biol Med. 2016;93:145–154.
   PubMed Web of Science ®Google Scholar
• Pu Y, Zhao Z, Li Y, et al. Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol Cell. 2016;62(2):284–294.
   PubMed Web of Science ®Google Scholar